Animals exhibiting small tumors (between 10 and 80 mm3 at day 20) were subsequently fed with a doxycycline containing diet (dox+) to silence ERK5 in breast cancer cells, or with a standard doxycycline-free (dox−) control diet. Here, MAPK7 is linked to breast cancer.